Source Precision Medicine, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Source Precision Medicine, Inc..The latest application filed is for "assessment of effect of an agent on a human biological condition using rodent gene expression panels".

Company Profile

0.6.7

Source Precision Medicine, Inc. - Boulder CO
SOURCE PRECISION MEDICINE, INC. d/b/a SOURCE MDX - Boulder CO
Source Precision Medicine, Inc. -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles Grant 7,957,909 - Bevilacqua , et al. June 7, 2	2011-06-07
Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis Grant 7,935,482 - Bankaitis-Davis , et al. May 3, 2	2011-05-03
Assessment Of Effect Of An Agent On A Human Biological Condition Using Rodent Gene Expression Panels App 20110092390 - Bevilacqua; Michael ; et al.	2011-04-21
Gene Expression Profiling for Identification, Monitoring and Treatment of Prostate Cancer App 20100233691 - Bankaitis-Davis; Danute M. ; et al.	2010-09-16
Gene Expression Profiling for Identification, Monitoring and Treatment of Ovarian Cancer App 20100216137 - Bankaitis-Davis; Danute ; et al.	2010-08-26
Gene Expression Profiling for Identification, Monitoring and Treatment of Lung Cancer App 20100184034 - Bankaitis-Davis; Danute M. ; et al.	2010-07-22
Identification, Monitoring and Treatment of Disease and Characterization of Biological Condition Using Gene Expression Profiles App 20100086935 - Bevilacqua; Michael P. ; et al.	2010-04-08
Quantitative assay for low abundance molecules Grant 7,074,586 - Cheronis , et al. July 11, 2	2006-07-11
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles App 20050287576 - Bevilacqua, Michael P. ; et al.	2005-12-29
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles Grant 6,964,850 - Bevilacqua , et al. November 15, 2	2005-11-15
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles App 20050250148 - Bevilacqua, Michael P. ; et al.	2005-11-10
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles Grant 6,960,439 - Bevilacqua , et al. November 1, 2	2005-11-01
Systems and methods for characterizing a biological condition or agent using precision gene expression profiles Grant 6,692,916 - Bevilacqua , et al. February 17, 2	2004-02-17

Company Registrations

NCAGE Code	1WXD5	SOURCE PRECISION MEDICINE INC.!DBA SOURCE BIOPHARMACEUTICALS
CAGE Code	1WXD5	SOURCE PRECISION MEDICINE, INC. SOURCE BIOPHARMACEUTICALS
DUNS	095678988	SOURCE PRECISION MEDICINE, INC.
SEC	0001077396	SOURCE PRECISION MEDICINE, INC. of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.